The characteristics of systemic lupus erythematosus: A study in a general hospital

Saudi Medical Journal

Volumn 21, Issue 3, 2000, Pages 282-286

  Karadsheh, Mansour F ^a,b   Nimri, Farah A ^a   Ajlouni, Yousef M ^a   Dneibat, Wael A ^a   Karadsheh, Rasha F ^a  

^a KING HUSSEIN MEDICAL CENTER   (Jordan)

^b NONE   (Jordan)

Author keywords

Complications; Systemic Lupus Erythematous

Indexed keywords

ANTIINFLAMMATORY AGENT; IMMUNOSUPPRESSIVE AGENT; STEROID;

ADOLESCENT; ADULT; AGE DISTRIBUTION; AGED; ARTICLE; BLOOD; CHILD; DISEASE COURSE; FEMALE; GENERAL HOSPITAL; HUMAN; INCIDENCE; JORDAN; MALE; MIDDLE AGED; RETROSPECTIVE STUDY; RISK FACTOR; SEX RATIO; SYSTEMIC LUPUS ERYTHEMATOSUS;

ADOLESCENT; ADULT; AGE DISTRIBUTION; AGED; ANTI-INFLAMMATORY AGENTS; CHILD; DISEASE PROGRESSION; FEMALE; HOSPITALS, GENERAL; HUMANS; IMMUNOSUPPRESSIVE AGENTS; INCIDENCE; JORDAN; LUPUS ERYTHEMATOSUS, SYSTEMIC; MALE; MIDDLE AGED; RETROSPECTIVE STUDIES; RISK FACTORS; SEX DISTRIBUTION; STEROIDS;

EID: 0034157617     PISSN: 03795284     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (28)

1. Hall FC, Walport MJ. Systemic lupus erythematosus. Medicine Int 1998: 5-11.
2. Hay EM, Snaith ML. Systemic lupus erythematosus and lupus-like syndromes. In: ABC of rheumatology. 1st ed. BMJ publishing group 1996; 60-64.
3. Blakemore AI, Tarlow JK, Cork MJ, Gordon C, Emery P, Duff GW. Interleukin-1 receptor antagonist gene polymorphism as a disease severity factor in systemic lupus erythematosus. Arthritis & Rheumatism 1994; 37: 1380-1385
4. Gladman D, Ginzler E, Goldsmith C, Fortin P, Liang M, Urowtz M. The development and initial validation of the systemic lupus international collaborating clinics/American college of rheumatology damage index for systemic lupus erythematosus. Arthritis & Rheumatism 1996; 39: 363-369.
5. Urowitz MB, Gladman DD, Abu-Shakra M, Farewell VT. Mortality studies in systemic lupus erythematosus. Results from a single centre III. J Rheumatol 1997; 24: 1061-1065.
6. Reveille JD, Moulds JM, Ahn C, Friedman AW, Haethge R, Roseman J et al. For the Lumina study. Systemic lupus erythematosus in three ethnic groups. I. The effect of HLA class II, C4 and CR1, socioeconomic factors and ethnicity at disease onset. Arthritis Rheum 1998; 41: 1161-1172.
7. Alarcon GS, Roseman J, Bartolucci AA, Friedman AW, Moulds JM, Goel N et al. Systemic lupus erythermatosis in three ethnic groups. Features predictive of disease activity early in its course. LUMINA Study Group Arthritis Rheum 1998; 41: 1173-1180.
8. Manger K, Repp R, Spriewald BM, Raseu A, Geiger A, Wassmuth R et al. Feγ receptor IIa polymorphism in caucasien patients with systemic lupus erythematosus. Association with clinical symptoms. Arthritis Rheum 1998; 41: 1181-1189.
9. Hahn BH. Pathogenesis of systemic lupus erythematosus. In: Kelly WN, Harris ED, Ruddy S, Sledge CB. Textbook of Rheumatology. 5th edition. WB Saunders Company. USA 1997; 1015-1027.
10. Petri M. The effect of race on incidence and clinical course in systemic lupus erythematosus: The Hopkins Lupus Cohort. [Abstract]. J Am Med Womens Assoc 1998; 53: 9-12.
11. Snaith ML, Isenberg DA. Systemic lupus erythematosus and related disorders. In: Weatherall DJ, Ledingham GG, Warrell DA. Oxford textbook of Medicine. 1996, Oxford University Press. UK. 3017-3026.
12. Ward MM, Studenski S. Clinical manifestations of systemic lupus erythematosus. Identification of racial and socioeconomic influences. Arch Intern Med 1990; 150: 849-853.
13. Samanta A, Feehally J, Roy S, Nichol FE, Sheldon PJ, Walls J. High prevalence of systemic disease and mortality in Asian subjects with systemic lupus erythematosus. Ann Rheum Dis 1991; 50: 490-492.
14. Zhang J, Zhou F, Ai R. Study on some susceptible genes of systemic lupus erythematosus in Han nationality in China. [Abstract]. Chinese J of Int Med 1996; 35: 19-22.
15. Mountz JD, Wu J, Cheng J, Zhou T. Autoimmune disease. A problem of defective apoptosis. Arthritis Rheum 1994; 37: 1415-1420.
16. Cancy RM, Amin AR, Abramson SB. The role of nitric oxide in inflammation and immunity. Arthritis Rheum 1998; 41: 1141-1151.
17. Al-Attia HM. Clinicolaboratory profile of 33 Arabs with systemic lupus erythematosus. Postgrad Med J 1996: 72: 677-679.
18. Al-Attia HM, George S. Characterization of systemic lupus erythematosus in patients in UAE. Clin Rheumatol 1995; 14: 171-175.
19. Alballa SR. Systemic lupus erythematosus in Saudi patients. Clin Rheumatol 1995; 14: 342-346.
20. Johnson AE, Gordon C, Hobbs FD, Bacon PA. Undiagnosed systemic lupus erythematosus in the community. Lancet 1996; 347: 367-369.
21. Denburg SD, Carbotte RM, Denburg JA. Corticosteroids and neuropsychological functioning in patients with systemic lupus erythematosus. Arthritis Rheum 1994; 37: 1311-1320.
22. Jarek MJ, West SG, Baker MR, Rak KM. Magnetic resonance imaging in systemic lupus erythematosus patients without a history of neuropsychiatric lupus erythematosus. Arthritis Rheum 1994; 37: 1609-1613.
23. Charles PJ, Maini RN. Autoantibodies in systemic autoimmune rheumatic diseases. Medicine 1998; 2-4.
24. Villarreal GM, Drenkard C, Villa AR, Slor H, Shafir S, Bakimer R et al. Prevalence of 13 autoantibodies and of the 16/6 and related pathogenic idiotypes in 465 patients with systemic lupus erythematosus and their relation ship to disease activity. Lupus 1997; 6: 423-435.
25. Smith EM, Samadian S. Use of erythrocyte sedimentation rate in the elderly. Br J Hosp Med 1994; 51: 394-397.
26. Wahl DG, Guillemin F, De-Maistre E, Perret C, Lecompte T, Thibaut G. Risk of venous thrombosis related to antiphospholipd antibodies in systemic lupus erythematosus. A meta-analysis. Lupus 1997; 6: 467-473.
27. Lafkowith JB, Gilkeson GS. Nephritogenic autoantibodies in lupus. Current concepts and continuing controversies. Arthritis Rheum 1996; 39: 894-903.
28. The frequency of autoantibodies in Turkish patients with lupus nephritis. [Abstract]. Rheumatol Int 1997; 17: 1-4.